Henry Schein (HSIC) Stock Price, News & Analysis

Company Overview

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Key Stats

• Today's Range: $68.43 to $69.21
• 50-Day Range: $62.70 to $75.45
• 52-Week Range: $60.56 to $82.49
• Volume: 107,495 shs
• Average Volume: 1.62 million shs
• Market Capitalization: $8.42 billion
• P/E Ratio: 28.30
• Dividend Yield: N/A
• Price Target: $79.30
• Consensus Rating: Moderate Buy

Henry Schein Stock Analysis - MarketRank™

Henry Schein scored higher than 66% of companies evaluated by MarketBeat, and ranked 323rd out of 912 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Henry Schein has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 5.91%

Earnings Growth

Earnings for Henry Schein are expected to grow by 5.91% in the coming year, from $4.74 to $5.02 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Henry Schein is 28.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.33.

Price to Earnings Ratio vs. Sector

The P/E ratio of Henry Schein is 28.25, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.99.

Price to Earnings Growth Ratio

Henry Schein has a PEG Ratio of 2.13. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Henry Schein has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.72% of the float of Henry Schein has been sold short.

Short Interest Ratio / Days to Cover

Henry Schein has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Henry Schein has recently increased by 0.20%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Henry Schein does not currently pay a dividend.

Dividend Growth

Henry Schein does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.4 / 5
• Environmental Score: -1.42

Percentage of Shares Shorted

4.72% of the float of Henry Schein has been sold short.

Short Interest Ratio / Days to Cover

Henry Schein has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Henry Schein has recently increased by 0.20%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.55

News Sentiment

Henry Schein has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 59 news articles for Henry Schein this week, compared to 11 articles on an average week.

Search Interest

Only 2 people have searched for HSIC on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Henry Schein insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $472,150.00 in company stock.

Percentage Held by Insiders

Only 1.08% of the stock of Henry Schein is held by insiders.

Percentage Held by Institutions

96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HSIC Stock Analysis - Frequently Asked Questions

How have HSIC shares performed this year?

Henry Schein's stock was trading at $69.20 at the beginning of 2025. Since then, HSIC shares have decreased by 0.3% and is now trading at $68.9660.
View the best growth stocks for 2025 here.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings results on Monday, May, 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein's revenue for the quarter was down .1% on a year-over-year basis.

When did Henry Schein's stock split?

Henry Schein's stock split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Does Henry Schein have any subsidiaries?

Henry Schein subsidiaries include Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and more.

Who are Henry Schein's major shareholders?

Henry Schein's top institutional investors include Pzena Investment Management LLC (0.79%), DekaBank Deutsche Girozentrale (0.78%), Bank of New York Mellon Corp (0.65%) and Private Management Group Inc. (0.28%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Gerald A Benjamin, Michael S Ettinger, Lorelei Mcglynn, Mark E Mlotek, David B Brous Jr, Bradford C Connett, Philip A Laskawy and Kurt P Kuehn.
View institutional ownership trends.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), AUO (AUOTY) and The RMR Group (RMR).

Company Calendar

• Last Earnings: 5/05/2025
• Today: 5/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical & hospital equipment
• Sub-Industry: Health Care Distributors
• Current Symbol: NASDAQ:HSIC
• CIK: 1000228
• Web: www.henryschein.com
• Phone: (631) 843-5500
• Fax: 631-843-5541
• Employees: 22,000
• Year Founded: 1932

Price Target and Rating

• Average Stock Price Target: $79.30
• High Stock Price Target: $86.00
• Low Stock Price Target: $74.00
• Potential Upside/Downside: +15.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.64
• Research Coverage: 11 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.20
• Trailing P/E Ratio: 28.35
• Forward P/E Ratio: 14.53
• P/E Growth: 2.13
• Net Income: $416 million
• Net Margins: 2.51%
• Pretax Margin: 3.21%
• Return on Equity: 12.90%
• Return on Assets: 5.21%

Debt

• Debt-to-Equity Ratio: 0.46
• Current Ratio: 1.42
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $12.67 billion
• Price / Sales: 0.67
• Cash Flow: $5.90 per share
• Price / Cash Flow: 11.68
• Book Value: $33.01 per share
• Price / Book: 2.09

Miscellaneous

• Outstanding Shares: 122,512,000
• Free Float: 123,260,000
• Market Cap: $8.44 billion
• Optionable: Optionable
• Beta: 0.87